Menu Back to 18th-DIA-Japan-Annual-Meeting-2021

Overview

Virtual Event

Click Here to View the Program (PDF as of August 4th)

Click Here to View the Agenda on the Japan Annual Meeting Website

Under the theme of “New Challenges, New Solutions: to overcome with people all over the world together”, this year’s JAM will provide opportunities for stakeholders from industry, government, academia, and patient bodies to look back at what we have accomplished and learned during the COVID-19 pandemic and engage in deeper dialogues as we move to the next stage.

This year’s conference will be held entirely online through a fully integrated platform offering live and on-demand content, 1-2-1 chat and Community meetups, live Q&A during sessions and much more! Sessions will also be available to view for one month following the live event. Breaking walls and boundaries, the virtual platform will enable you to join the event from wherever you may be and to connect with fellow professionals from across the world.

We look forward to your participation!

Super Early Bird savings available thru August 24th! Click Register below to save your seat.

Program Committee

  • E. Stewart  Geary, MD
    E. Stewart Geary, MD Senior VP, Global Safety Officer, Director, Corporate Medical Affairs HQ
    Eisai Co., Ltd., Japan
  • Rie  Matsui, RPh
    Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC
    Pfizer, Japan
  • Katsuhiko  Ichimaru
    Katsuhiko Ichimaru Review Director, Office of New Drug IV
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Kazuhiko  Ishida, MSc, RPh
    Kazuhiko Ishida, MSc, RPh
    Astellas Pharma Inc., Japan
  • Tomoyuki  Kakizume, PhD
    Tomoyuki Kakizume, PhD Statistical & Quantitative Sciences
    Takeda Pharmaceutical Co. Ltd.,, Japan
  • Miyuki  Kaneko
    Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
    Pfizer R&D Japan, Japan
  • Yukihiro  Matsuda, MSc
    Yukihiro Matsuda, MSc Project Manager, Project Leadership
    PRA Health Sciences K.K., Japan
  • Yukiko  Nishimura, PhD, MSc
    Yukiko Nishimura, PhD, MSc President
    NPO ASrid, Japan
  • Mika  Ogasawara
    Mika Ogasawara Quality Lead, Biometrics and Data Management
    Pfizer R&D Japan, Japan
  • Takashi  Sato, MSc, PMP
    Takashi Sato, MSc, PMP Manager, Project Management Group, Development Unit
    Kyowa Kirin Co., Ltd., Japan
  • Katsuhiko  Sawada, MPharm
    Katsuhiko Sawada, MPharm Director, Research and Development Dept.
    Otsuka Medical Devices Co.Ltd., Japan
  • Kazuyuki  Suzuki, MSc
    Kazuyuki Suzuki, MSc Oncology Trial Management Group, Trial Management Department, Japan Development
    Novartis Pharma K.K., Japan
  • Keiko  Tsumori
    Keiko Tsumori Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Nariaki  Uemura
    Nariaki Uemura Senior Associate, Depelopment
    Astellas Pharma Inc., Japan
  • Tadashi  Urashima, PhD
    Tadashi Urashima, PhD Performance and Digital Analytics Lead, Medical & Development Excellence Japan
    GlaxoSmithKline K.K., Japan
  • Koichiro  Yuji, MD, PhD, FACP
    Koichiro Yuji, MD, PhD, FACP Project Associate Professor, The Institute of Medical Science
    The University of Tokyo, Japan
  • Keiichi  Inaizumi, MSc
    Keiichi Inaizumi, MSc Japan Clinical Project Manager, Clinical Operations and Compliance 1
    Pfizer R&D Japan, Japan
  • Junichi  Nishino, MSc, RPh
    Junichi Nishino, MSc, RPh Head, Regulatory Affairs Department
    Otsuka Pharmaceutical Co., Ltd., Japan
  • Hironobu  Saito, PhD
    Hironobu Saito, PhD Corporate Officer /Head of Medical Affairs Div.
    Daiichi Sankyo Co., Ltd., Japan
  • Junko  Sato, PhD
    Junko Sato, PhD Director, Office of International Programs
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Atsushi  Tsukamoto, PhD, MSc
    Atsushi Tsukamoto, PhD, MSc Vice President, Ne Drug Regulatory Affairs Department
    Daiichi Sankyo Company, Limited, Japan
Load More

Contact us